September 6, 2019

For Immediate Release

OTTAWA – Health Canada is advising Canadians who use vaping products to monitor themselves for symptoms of pulmonary illness (e.g., cough, shortness of breath, chest pain) and to seek medical attention promptly if they have concerns about their health.

This caution comes in the wake of the recent cases of acute pulmonary illnesses and several deaths reportedly linked to the use of vaping products in the United States. The United States Food and Drug Administration (US FDA) and the Centers for Disease Control and Prevention (US CDC) released a statement August 30 on their ongoing investigation into the cause of the illnesses. The same day, the US CDC issued an official health advisory. On September 6, the US CDC released publications to provide an update on the status of the investigation. The source of the illnesses remains unclear at this time; however, the US CDC reports that chemical exposure is the likely cause. Many patients have reported vaping tetrahydrocannabinol (THC) and/or nicotine-containing products. However, at this time no specific product, substance or device has been linked to all cases of vaping illness in the U.S.

To date, the Government of Canada has not seen any evidence of similar pulmonary illnesses occurring in Canada. Health Canada and the Public Health Agency of Canada are actively monitoring the situation in the U.S. and are in close contact with the US FDA and the US CDC to better understand their investigation into the cause of the illnesses.

The Public Health Agency of Canada continues to engage with provincial and territorial public health officials and has asked them to report possible incidents of pulmonary illness associated with vaping in their jurisdictions. The Government of Canada is monitoring all available data sources for indications of similar issues in Canada, and will take action, as appropriate, to protect the health and safety of Canadians. Canadians will be informed as more details become available.

Vaping is not without risk, and the potential long-term effects of vaping remain unknown. Non-smokers, people who are pregnant and young people should not vape.

Canadians are reminded that the purchase of vaping products outside the legal market may create additional risk as these products are unregulated and potentially unsafe, and thereby pose a risk to health and safety.

Health care professionals are reminded to always ask patients, as part of their general history, whether they use drugs from any source, whether legal or illegal. When patients present with respiratory symptoms, especially if the cause is unclear, health care professionals should ask about the use of electronic cigarette (e-cigarette) products—such as devices, liquids, refill pods and/or cartridges—for vaping.